BigCommerce Announces Exercise in Full of the Over-Allotment Option in Follow-on Public Offering

AUSTIN, Texas, Nov. 20, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce” or the “Company”) (Nasdaq: BIGC) today announced the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of the Company’s Series 1 common stock from certain selling stockholders at a price to the public of $68.00 per share in connection with the previously announced follow-on public offering of its Series 1 common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”). The Company will not receive any proceeds from the sale of the additional 750,000 shares of Series 1 common stock by selling stockholders. The initial closing of the offering occurred on November 17, 2020.

J.P. Morgan and Barclays served as lead book-running managers for the proposed offering. Morgan Stanley, Jefferies and KeyBanc Capital Markets acted as book-running managers. Canaccord Genuity, Needham & Company, Piper Sandler, Raymond James, Stifel and Truist Securities acted as co-managers for the offering.

A registration statement relating to these securities was declared effective by the SEC on November 12, 2020. The offering is being made only by means of a prospectus. A copy of the prospectus may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 866-803-9204; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (888) 603-5847 or by email at [email protected].

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About BigCommerce

BigCommerce is a leading software-as-a-service (SaaS) ecommerce platform that simplifies the creation of beautiful, engaging online stores by delivering a unique combination of ease-of-use, enterprise functionality, and flexibility. BigCommerce powers both our customers’ branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. As of September 30, 2020, BigCommerce served approximately 60,000 online stores across industries in approximately 150 countries, including Ben & Jerry’s, Skullcandy, Sony, and Woolrich. Headquartered in Austin, BigCommerce has offices in San Francisco, Sydney, and London.

BigCommerce® is a registered trademark of BigCommerce Pty. Ltd. Third-party trademarks and service marks are the property of their respective owners.

Media Relations Contact

Rachael Hensley
[email protected]
ICR PR for BigCommerce
[email protected]

Investor Relations Contact

Rohit Giri
[email protected]



Norwegian Cruise Line Holdings Ltd. Announces Closing of 40,000,000 Ordinary Shares

MIAMI, Nov. 20, 2020 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) announced today that it has closed its underwritten public offering of 40,000,000 ordinary shares of the Company (the “Offering”) at a price to the public of $20.80 per share. The Company expects to use the net proceeds from the Offering for general corporate purposes.

Barclays and J.P. Morgan acted as the underwriters for the Offering.

The Offering was made under an automatic shelf registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 17, 2020. The Offering was made only by means of a prospectus supplement and an accompanying base prospectus. A prospectus supplement and accompanying base prospectus relating to the Offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov, copies of which may be obtained by contacting Barclays Capital Inc., Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (888) 603-5847, or by emailing [email protected], or by contacting J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (866) 803-9204, or by emailing [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration and qualification under the securities laws of such state or jurisdiction.

About Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150 berths, these brands offer itineraries to more than 490 destinations worldwide. The Company has nine additional ships scheduled for delivery through 2027.

Cautionary Statement Concerning Forward-Looking Statements

Some of the statements, estimates or projections contained in this press release are “forward-looking statements” within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including, without limitation, those regarding our business strategy, financial position, results of operations, plans, prospects, actions taken or strategies being considered with respect to our liquidity position, valuation and appraisals of our assets and objectives of management for future operations (including those regarding expected fleet additions, our voluntary suspension, our ability to weather the impacts of the COVID-19 pandemic, our expectations regarding the resumption of cruise voyages and the timing for such resumption of cruise voyages, the implementation of and effectiveness of our health and safety protocols, operational position, demand for voyages, financing opportunities and extensions, and future cost mitigation and cash conservation efforts and efforts to reduce operating expenses and capital expenditures) are forward-looking statements. Many, but not all, of these statements can be found by looking for words like “expect,” “anticipate,” “goal,” “project,” “plan,” “believe,” “seek,” “will,” “may,” “forecast,” “estimate,” “intend,” “future” and similar words. Forward-looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to, the impact of:

  • the spread of epidemics, pandemics and viral outbreaks and specifically, the COVID-19 pandemic, including its effect on the ability or desire of people to travel (including on cruises), which are expected to continue to adversely impact our results, operations, outlook, plans, goals, growth, reputation, cash flows, liquidity, demand for voyages and share price;
  • our ability to comply with the U.S. Centers for Disease Control and Prevention (“CDC”) Framework for Conditional Sailing Order and to otherwise develop enhanced health and safety protocols to adapt to the current pandemic environment’s unique challenges once operations resume and to otherwise safely resume our operations when conditions allow;
  • coordination and cooperation with the CDC, the federal government and global public health authorities to take precautions to protect the health, safety and security of guests, crew and the communities visited and the implementation of any such precautions;
  • our ability to work with lenders and others or otherwise pursue options to defer, renegotiate or refinance our existing debt profile, near-term debt amortization, newbuild related payments and other obligations and to work with credit card processors to satisfy current or potential future demands for collateral on cash advanced from customers relating to future cruises;
  • our potential future need for additional financing, which may not be available on favorable terms, or at all, and may be dilutive to existing shareholders;
  • our indebtedness and restrictions in the agreements governing our indebtedness that require us to maintain minimum levels of liquidity and otherwise limit our flexibility in operating our business, including the significant portion of assets that are collateral under these agreements;
  • the accuracy of any appraisals of our assets as a result of the impact of COVID-19 or otherwise;
  • our success in reducing operating expenses and capital expenditures and the impact of any such reductions;
  • our guests’ election to take cash refunds in lieu of future cruise credits or the continuation of any trends relating to such election;
  • trends in, or changes to, future bookings and our ability to take future reservations and receive deposits related thereto;
  • the unavailability of ports of call;
  • future increases in the price of, or major changes or reduction in, commercial airline services;
  • adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events;
  • adverse incidents involving cruise ships;
  • adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence;
  • any further impairment of our trademarks, trade names or goodwill;
  • breaches in data security or other disturbances to our information technology and other networks or our actual or perceived failure to comply with requirements regarding data privacy and protection;
  • changes in fuel prices and the type of fuel we are permitted to use and/or other cruise operating costs;
  • mechanical malfunctions and repairs, delays in our shipbuilding program, maintenance and refurbishments and the consolidation of qualified shipyard facilities;
  • the risks and increased costs associated with operating internationally;
  • fluctuations in foreign currency exchange rates;
  • overcapacity in key markets or globally;
  • our expansion into and investments in new markets;
  • our inability to obtain adequate insurance coverage;
  • pending or threatened litigation, investigations and enforcement actions;
  • volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees;
  • our inability to recruit or retain qualified personnel or the loss of key personnel or employee relations issues;
  • our reliance on third parties to provide hotel management services for certain ships and certain other services;
  • our inability to keep pace with developments in technology;
  • changes involving the tax and environmental regulatory regimes in which we operate; and
  • other factors set forth under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 27, 2020, as updated by our Current Report on Form 8-K filed on July 8, 2020, and our Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020.

Additionally, many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic. It is not possible to predict or identify all such risks. There may be additional risks that we consider immaterial or which are unknown.

The above examples are not exhaustive and new risks emerge from time to time. Such forward-looking statements are based on our current beliefs, assumptions, expectations, estimates and projections regarding our present and future business strategies and the environment in which we expect to operate in the future. These forward-looking statements speak only as of the date made.

We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based, except as required by law.

Investor Relations & Media Contact

Andrea DeMarco
(305) 468-2339
[email protected]

Jessica John
(786) 913-2902



Recharge Acquisition Corp. Announces Separate Trading of its Class A Common Stock and Warrants, Commencing on or about November 23, 2020

New York, NY, Nov. 20, 2020 (GLOBE NEWSWIRE) — Recharge Acquisition Corp. (Nasdaq: RCHGU) (the “Company”) announced today that, commencing on or about November 23, 2020, holders of the 20,040,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and warrants included in the units. Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols “RCHG” and “RCHGW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on The Nasdaq Capital Market under the symbol “RCHGU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into shares of Class A common stock and warrants.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”) and declared effective on September 30, 2020.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on companies in the convenience store industry. The Company is led by Chairman, Rajesh Soin, Chief Executive Officer, Anthony Kenney, and Chief Financial Officer, Michael Gearhardt.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements.” Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.  

Contact

Anthony Kenney
Recharge Acquisition Corp.
(937) 610-4057



Kodiak Sciences Announces Closing of $645.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

PR Newswire

PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced the closing of its previously announced underwritten public offering of 5,972,222 shares of its common stock, which includes 778,985 shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional shares, at a price to the public of $108.00 per share. The aggregate gross proceeds from the offering were approximately $645.0 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Kodiak Sciences.

J.P. Morgan, Morgan Stanley, Jefferies and Evercore ISI acted as joint book-running managers for the offering. Truist Securities acted as lead manager.

The shares described above were offered by Kodiak Sciences pursuant to an effective shelf registration statement on Form S-3, including a base prospectus, that was previously filed by Kodiak Sciences with the Securities and Exchange Commission (the “SEC”). A final prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at [email protected]; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014 or by email at [email protected]; Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388, or by email at [email protected]; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 36th Floor, New York, NY 10055, by telephone at (888) 474-0200, or by email at [email protected].  

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Kodiak Sciences Inc.

Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, we are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Kodiak’s lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including age-related macular degeneration, a leading cause of blindness in elderly patients, and diabetic eye diseases, a leading cause of blindness in working-age patients.

Kodiak®, Kodiak Sciences®, ABC™, ABC Platform™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

Cision View original content:http://www.prnewswire.com/news-releases/kodiak-sciences-announces-closing-of-645-0-million-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-301178117.html

SOURCE Kodiak Sciences Inc.

Penfund Announces US$85 Million Investment in Arrowhead Engineered Products

TORONTO, Nov. 20, 2020 (GLOBE NEWSWIRE) — Penfund, an independent provider of junior capital to North American middle market companies, announced today the completion of a US$85 million second lien debt investment in Arrowhead Engineered Products, a portfolio company of The Riverside Company and Investcorp.

Headquartered in Blaine, Minnesota, Arrowhead is a specialty supplier and distributor of aftermarket replacement parts for a wide variety of equipment types across the outdoor power equipment, powersports, agricultural, industrial and automotive industries. The company is a critical supply chain partner to a fragmented supplier and customer base in both North America and Europe and offers over 100,000 SKUs.

“We are delighted to invest in Arrowhead and to partner with both Riverside and Investcorp. We believe the stable, niche end-markets in which Arrowhead operates, along with its defensible market position and stable customer relationships, make it an attractive partnership opportunity,” stated Adam Breslin, a partner at Penfund.

Nicole Fich, a partner at Penfund, added, “We are excited to partner with such a strong platform. Arrowhead’s strong ecommerce capabilities make it uniquely positioned to thrive today and going forward.”

About
Arrowhead Engineered Products

Arrowhead Engineered Products is a leading supplier of non-discretionary, mission-critical, aftermarket replacement parts for a wide variety of motorized vehicles and equipment types. Based in Blaine, Minnesota, Arrowhead has established locations in the United States, Canada, Europe, Asia and South America.

Website: www.arrowheadepinc.com

About Penfund

Penfund is a leading provider of junior capital to middle market companies throughout North America. The firm is owned by its management team and is currently investing its most recently established fund, Penfund Capital Fund VI. Penfund manages funds sourced from pension funds, insurance companies, banks, family offices and high-net-worth individuals located in Canada, the United States, the Middle East and Europe. Penfund has invested more than C$3 billion in over 225 companies since its establishment. Assets under management are approximately C$1.5 billion.

Website: www.penfund.com

Contacts:

Penfund
Richard Bradlow
Partner
(416) 645-3794
[email protected]
Penfund
Adam Breslin
Partner
(416) 645-3796
abreslin@penfund.com
Penfund
Nicole Fich
Partner
(416) 645-3791
nfich@penfund.com
     
Penfund
Joe Mattina
Partner
(647) 776-2164
[email protected]
Penfund
Jeremy Thompson
Partner
(416) 645-3790
[email protected]
 

 



Prospect Capital Corporation Announces Change to Virtual Meeting for 2020 Annual Meeting of Stockholders

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — Prospect Capital Corporation (Nasdaq: PSEC) (the “Company”) announced today that its annual meeting of stockholders, scheduled for Wednesday, December 2, 2020, at 3:30 p.m. EST (with any postponements or adjournments, the “Annual Meeting”), will be held by Internet webcast in order to mitigate potential risks to the health and safety of the Company’s stockholders, directors, service providers, personnel and other stakeholders arising from the public health impact of the coronavirus outbreak.

If you are a stockholder as of the record date you may participate in the Annual Meeting via live audio webcast by visiting the following website and following the registration and participation instructions contained therein: www.virtualshareholdermeeting.com/PSEC2020

  • If you hold your shares directly, please have the 16-digit control number located on your proxy card or notice available.
  • If you hold your shares in “street name” (i.e., through an account at a broker or other nominee), please follow your broker’s or nominee’s instructions you previously received to obtain your 16-digit control number.
  • If you are a stockholder of record (i.e., your shares are registered in your name with American Stock Transfer & Trust (“AST”)) and want the ability to vote or ask a question at the Annual Meeting, you must contact AST via email ([email protected]) to request a control number by December 1, 2020.

If you do not have your control number, you may still attend the Annual Meeting as a guest but will not have the option to ask questions or vote your shares during the meeting.

The agenda for the Annual Meeting is unchanged from the proxy statement dated September 28, 2020, and the proxy statement and proxy card that were mailed to record date stockholders on or about that date remain valid. Stockholders of record at the close of business on September 14, 2020 are entitled to attend and vote at the Annual Meeting. We encourage you to access the Annual Meeting 15 minutes prior to the start time. Online check-in will begin at 3:15 p.m. EST.

If you have already voted by mail, by telephone or online, you do not need to do anything further to vote your shares. If you have any other questions about the Annual Meeting or about voting, please call our solicitor, AST Fund Solutions, LLC, at (866) 387-0770.

Whether or not stockholders plan to attend the virtual-only Annual Meeting, the Company urges stockholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.

THIS NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.

IF YOU HAVE NOT YET VOTED, PROSPECT CAPITAL CORPORATION NEEDS YOUR VOTE IMMEDIATELY.

For further information, contact:

Investor Relations
Telephone (212) 448-0702



Priority Income Fund, Inc. Announces Change to Virtual Meeting for 2020 Annual Meeting of Stockholders

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) — Priority Income Fund, Inc. (the “Company”) announced today that its annual meeting of stockholders, scheduled for Wednesday, December 2, 2020, at 2:30 p.m. (with any postponements or adjournments, the “Annual Meeting”), will be held by Internet webcast in order to mitigate potential risks to the health and safety of the Company’s stockholders, directors, service providers, personnel and other stakeholders arising from the public health impact of the coronavirus outbreak.

If you are a stockholder as of the record date you may participate in the Annual Meeting via live audio webcast by visiting the following website and following the registration and participation instructions contained therein: www.virtualshareholdermeeting.com/PRIFA2020.

  • If you hold your shares in “street name” (i.e., through an account at a broker or other nominee), please follow your broker’s or nominee’s instructions you previously received to obtain your 16-digit control number.
  • If you are a stockholder of record (i.e., your shares are registered in your name with DST Systems, Inc.) and want to attend the Annual Meeting, you must contact American Stock Transfer & Trust via email ([email protected]) to request a control number by December 1, 2020.

If you do not have your control number, you may still attend the Annual Meeting as a guest, but will not have the option to ask questions or vote your shares during the meeting

The agenda for the Annual Meeting is unchanged from the proxy statement dated September 18, 2020, and the proxy statement and proxy card that were mailed to record date stockholders on or about that date remain valid. Stockholders of record at the close of business on September 18, 2020 are entitled to attend and vote at the Annual Meeting. We encourage you to access the Annual Meeting 15 minutes prior to the start time. Online check-in will begin at 2:15 p.m. EST.

If you have already voted by mail, by telephone or online, you do not need to do anything further to vote your shares. If you have any other questions about the Annual Meeting or about voting, please call our solicitor, AST Fund Solutions, LLC, at (800) 967-0261.

Whether or not stockholders plan to attend the virtual-only Annual Meeting, the Company urges stockholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.

THIS NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.

For further information, contact:

Investor Relations
Telephone (212) 448-0702



LAIX Inc. to Hold 2020 Annual General Meeting on December 30, 2020

PR Newswire

SHANGHAI, Nov. 20, 2020 /PRNewswire/ — LAIX Inc. (NYSE: LAIX) (“LAIX” or the “Company”), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it will hold an annual general meeting of shareholders at 3/F, Building B, No. 1687 Changyang Road, Yangpu District, Shanghai, 200090, People’s Republic of China on December 30, 2020 at 10:00 a.m., local time.

Holders of record of ordinary shares of the Company at the close of business on November 30, 2020 are entitled to notice of, and to vote at, the annual general meeting or any adjournment or postponement thereof. Holders of the Company’s American depositary shares (“ADSs”) who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company’s ADS program, Deutsche Bank Trust Company Americas. The purpose of the annual general meeting is for the Company’s shareholders to consider, and if thought fit, approve the sixth amended and restated memorandum and articles of association of the Company.

The notice of the annual general meeting, which sets forth the resolutions to be submitted to shareholder approval at the meeting, is available on the Investor Relations section of the Company’s website at http://ir.laix.com/, as well as on the SEC’s website at http://www.sec.gov/.

About
LAIX
 Inc.

LAIX Inc. (“LAIX” or the “Company”) is an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning. Its proprietary AI teacher utilizes cutting-edge deep learning and adaptive learning technologies, big data, well-established education pedagogies and the mobile internet. LAIX believes its innovative approach fundamentally transforms learning. LAIX provides its products and services on demand via its mobile apps, primarily its flagship “English Liulishuo” mobile app launched in 2013. On the Company’s platform, AI technologies are seamlessly integrated with diverse learning content incorporating well-established language learning pedagogies, gamified features and strong social elements to deliver an engaging, adaptive learning experience. LAIX provides a variety of courses inspired by a broad range of topics and culture themes to make English learning more interesting and is committed to offering a fun, interactive learning environment to motivate and engage its users.

For investor and media inquiries, please contact:

LAIX Inc.
Harry He
Investor Relations
E-mail: [email protected]

The Piacente Group Investor Relations
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]

Emilie Wu

Tel: +86-21-6039-8363
E-mail: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/laix-inc-to-hold-2020-annual-general-meeting-on-december-30-2020-301177924.html

SOURCE LAIX Inc.

“Sneak Peek”: Taat Reveals First Placements of In-Store Graphics in Select Locations of Ohio Tobacco Retailers

The Company has undertaken efforts to prepare its in-store presence in select tobacco points of sale in Ohio that will be carrying Taat upon its launch this quarter. In addition to determining shelf positioning for Taat relative to competing products in the tobacco category, the Company is also placing promotional graphics such as posters in conspicuous places in stores with an objective of capturing the attention of current tobacco smokers of legal age at the point of sale. The Company’s Key Accounts Manager in Ohio, who spent more than a decade in sales at a “Big Tobacco” firm, has also issued a video statement regarding her observations in pre-launch sales activities for Taat.

LAS VEGAS and VANCOUVER, British Columbia, Nov. 20, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) is pleased to announce that it has begun placing in-store promotional graphics for Taat in select Ohio points of sale, in preparation for the official launch of Taat set to take place later this quarter. In a press release dated October 6, 2020, the Company announced it would be launching Taat, its flagship product, in the state of Ohio where it has secured distributorship with ADCO Distributors, Inc. (“ADCO”), a large Ohio tobacco wholesaler who has access to more than 5,000 tobacco points of sale in the state through direct and indirect relationships. ADCO is a distributor of tobacco products for some of the world’s largest tobacco companies to include the following:

  • Altria Group, Inc. (Parent company of several tobacco market leaders in the United States, including Philip Morris USA1, whose brands such as Marlboro had a 49.7% cigarette market share in the United States in 20192)
  • ITG Brands, LLC (Third-largest tobacco company in the United States, part of Imperial Brands PLC, brand portfolio includes Winston, Kool, Salem, and Maverick3)
  • RJ Reynolds Tobacco Company (Subsidiary of British American Tobacco, second-largest tobacco company in the United States with three of the top five cigarette brands in the United States including Newport, Camel, and Pall Mall, which in 2017 had a combined U.S. market share of 30%4)

In the Company’s October 30, 2020 press release, the rationale for choosing Ohio as Taat’s launch market was explained based on the unique merits of Ohio in comparison to other markets in the United States. Further detail was given in a video statement titled Four Reasons for Ohio, made by the Company’s Chief Executive Officer Setti Coscarella. To date, the Company has received an initial order for each of the Original, Smooth, and Menthol varieties of Taat from ADCO, its first distributor in Ohio. Further, an average of more than 100 Taat sample requests have been received per day through the Company’s TryTaat landing page (http://trytaat.com). As pre-launch interest in Taat continues to gain momentum, the Company has commenced in-store initiatives which include placing promotional materials in conspicuous areas of a given point of sale, with an objective of attracting the attention of current tobacco smokers of legal age to trial the product.

The Company has developed Beyond Tobacco™, the nicotine-free and tobacco-free base material of Taat, which is its flagship product. Engineered to closely emulate the experience of smoking a tobacco cigarette, Taat’s intended use case is to provide current tobacco smokers of legal age the choice of continuing to enjoy the experience of smoking, without consuming nicotine. Taat is being commercialized under the leadership of an executive team with considerable experience in the tobacco industry throughout North America. As of this writing, the Company is producing approximately 600 lb / 272 kg of Beyond Tobacco™ per day in its Las Vegas, NV processing facility, which is sufficient to manufacture a full pallet of 1,440 ten-pack cartons of Taat.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/88fc5953-caab-444b-a4fb-7d3ebce71f8b

Readers using news aggregation services may be unable to view the media above. Please access the

Investor Relations

section of the Company’s website for a version of this press release containing all published media.

Sales efforts for Taat in Ohio have been led by a Key Accounts Manager with more than a decade of sales experience for a “Big Tobacco” firm in the northeastern United States, in addition to a sales position for a well-known maker of vaping products. To provide insight regarding the Company’s sales activities in the state of Ohio, the Key Accounts Manager made a video statement summarizing all sales-related progress to date in advance of Taat’s launch. In the video statement, in-store footage is also shown to provide an example of the retail settings in which Taat is to be sold initially.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7f3e4fbd-267d-425e-9160-919e3392072f

Readers using news aggregation services may be unable to view the media above. Please access the

Investor Relations

section of the Company’s website for a version of this press release containing all published media.

Taat Chief Executive Officer Setti Coscarella commented, “It was less than two months ago that the provisional new pack designs for Taat were released, which brought us one step closer to being ready to sell Taat at retail. In just seven weeks since then, we secured distribution through a large tobacco wholesaler in Ohio who has already placed an initial order, made trademark filings in what is now a total of 15 jurisdictions, received and processed several tons of biomass for making Beyond Tobacco™, and launched our TryTaat landing page which has seen exceptional success so far. We are now at the point at which we are beginning to set up in-store promotional graphics as part of our awareness campaign, which began with our digital marketing efforts starting at the end of October 2020. With in-store promotional materials, our objective is to make current tobacco smokers of legal age in Ohio aware of the Taat brand in a context in which they can trial the product by purchasing it on the spot. With expert tobacco category sales leadership on the ground in Ohio, I am very pleased with the progress we have made in laying the groundwork to establish a sales pipeline in our launch market. I look forward to getting into motion in Ohio as we work towards a successful launch, which I hope we can replicate in new markets both in the United States and globally.”

ADCO Chief Operating Officer Pat Bell commented, “We have been in the tobacco wholesale business in Ohio since 1960, and in my time here I have observed many trends in terms of what sells in the tobacco category in this market. Although alternatives to smoking tobacco such as vaping appear to be popular, sales volumes for tobacco cigarettes have not dropped off drastically, which suggests that current smokers of legal age ultimately continue to smoke combustible products in the long run. Taat has taken an innovative approach to closely replicating the experience of smoking a tobacco cigarette, right down to the product and packaging formats which are similar to those of existing brands of tobacco cigarettes. Our sales team has been actively securing pre-orders for Taat products. As I anticipated, reactions from retailers for this product have been overwhelmingly positive. In addition to providing distribution of Taat to tobacco retailers in Ohio, we have already established redistribution agreements with several other wholesalers who also predict Taat can sell successfully in this market. We have been working hard behind the scenes to prepare for Taat’s launch here in Ohio, and I am excited for the first batch of Taat to arrive at our warehouse so that we can get to work on processing and sending out orders.”

Sources

1 – https://www.altria.com/about-altria?src=megaspotlight

2 – https://www.philipmorrisusa.com/company/about-pm-usa

3 – https://www.itgbrands.com/about-us/

4 – https://rjrt.com/transforming-tobacco/who-we-are/

On behalf of the Board of Directors of the Company,

TAAT LIFESTYLE & WELLNESS LTD.

“Setti Coscarella”

Setti Coscarella, CEO and Director

For further information, please contact:

Taat Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]

THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

About Taat Lifestyle & Wellness Ltd.

The Company has developed Taat, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original”, “Smooth”, and “Menthol” varieties. Taat’s base material is Beyond Tobacco™, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “Big Tobacco” pedigree, Taat is launching in the United States in Q4 2020 as the Company seeks to position itself in the $814 billion1 global tobacco industry.

For more information, please visit http://taatusa.com.

References

1

British American Tobacco – The Global Market

Forward Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the potential launch of Beyond Tobacco™, in addition to the following: Potential effects of the Company’s in-store promotional materials placed in tobacco retail stores in Ohio. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Disclosures relating to investor relations firms retained by Taat Lifestyle & Wellness Ltd. can be found under the Company’s profile on http://sedar.com.



The Boston Globe Names Beam Therapeutics a Top Place to Work for 2020

Magazine honors company for second year in a row

CAMBRIDGE, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today has been named one of the Top Places to Work in Massachusetts in the 13th annual employee-based survey project from The Boston Globe for the second year in a row. Top Places to Work recognizes the most admired workplaces in the state voted on by the people who know them best: their employees. The survey measures employee opinions about their company’s direction, execution, connection, management, work, pay and benefits, and engagement.

The employers are placed into one of four groups: small, with 50 to 99 employees; medium, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more. Beam was ranked as the top biotechnology company in the medium category and ranked 18 out of 55 in the category overall.

“Beam was undoubtedly a great place to work when we received this honor last year, and despite the unprecedented circumstances as a result of the global pandemic, it remains true in 2020,” said John Evans, chief executive officer of Beam Therapeutics. “COVID-19 has constantly challenged our teams to collaborate, innovate and stay connected in new ways. Our growth and progress over the course of 2020 speaks volumes to the exceptional values and commitment of every member of the Beam team.”

The rankings in Top Places to Work are based on confidential survey information collected by Energage, a Pennsylvania-based employee research and consulting firm specializing in employee engagement and retention, from over 80,000 employees at 285 Massachusetts organizations. The winners share a few key traits, including offering progressive benefits, giving their employees a voice, and encouraging them to have some fun while they’re at it.

“This was a particularly challenging year to be a great place to work, and the companies that made our list went above and beyond to keep their employees safe, engaged, and cared for,” said Katie Johnston, the Globe’s Top Places to Work editor. “From offering help with childcare to making the workplace more equitable to holding virtual talent shows, these employers showed that the best get better in crisis.”

About Beam Therapeutics

Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization focused on its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. For more information, visit www.Beamtx.com.

Contacts:

Media:
Dan Budwick
1AB
[email protected] 

Investors:
Monique Allaire
THRUST Strategic Communications
[email protected]